Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
about
Minimum inhibitory concentrations of equine Corynebacterium pseudotuberculosis isolates (1996-2012)Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumoniaACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance.Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus.Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development.Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.Comparative pharmacokinetics of minocycline in foals and adult horses.Use of Liposomal Gentamicin for Treatment of 5 Foals with Experimentally Induced Rhodococcus equi Pneumonia.Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA.Efficacy of mass antimicrobial treatment of foals with subclinical pulmonary abscesses associated with Rhodococcus equi.An epidemiologic study of antimicrobial resistance of Staphylococcus species isolated from equine samples submitted to a diagnostic laboratory.Development of septic polysynovitis and uveitis in foals experimentally infected with Rhodococcus equi.Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals.
P2860
Q36873579-2CEDC183-158D-441A-B76B-4A98060F7D5DQ36873583-CE93940F-4554-49BE-A1CB-6B012AD0C55BQ36975171-AC4B6C15-958A-4440-98E9-1540324B05CFQ37697676-065A83D1-F2E7-4148-B08D-8E66942236BCQ38221560-57618FFB-AE7B-4B6C-8776-EE32DB50DF75Q38390011-F7066A01-2513-4A7F-A034-26A35E30CDFAQ40523935-420D6054-8390-4255-B5FC-1B4BCE54CC35Q40861834-8E3A527A-3A58-4513-AB91-0CEC02C819CDQ40995814-BAB7B660-662D-4D43-AF6B-11EFE9E128FBQ41338773-FEF52585-9B0C-4A08-A14B-E452E3D103BEQ41672483-B9B6C498-8B47-421A-8EA9-514677308432Q42205018-985DF31A-C6B4-4E13-82E7-FF875929995EQ44266078-5FCB6276-C414-4FBD-909C-2E0BFD3F0873Q48103762-E452BB9C-E0F1-4BF0-A118-3A1C812FFBFAQ50133205-80C0EA89-4CE3-4982-B567-BAAFDE2E97B9Q51542940-0D4E2031-6459-4603-A86D-CD839F8DF46E
P2860
Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Determination of the prevalenc ...... -resistant isolates of R equi.
@en
Determination of the prevalenc ...... -resistant isolates of R equi.
@nl
type
label
Determination of the prevalenc ...... -resistant isolates of R equi.
@en
Determination of the prevalenc ...... -resistant isolates of R equi.
@nl
prefLabel
Determination of the prevalenc ...... -resistant isolates of R equi.
@en
Determination of the prevalenc ...... -resistant isolates of R equi.
@nl
P2093
P356
P1476
Determination of the prevalenc ...... -resistant isolates of R equi.
@en
P2093
Carol C Clark
Elliott Williams
M Keith Chaffin
Natalie Halbert
Nathan M Slovis
Robert P Franklin
Ronald J Martens
Steeve Giguère
P356
10.2460/JAVMA.237.1.74
P407
P50
P577
2010-07-01T00:00:00Z